Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders

References

• Ahlsen G, Rosengren L, Belfrage M, et al. (1993). Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry 33:734–43.
   PubMed Web of Science ®Google Scholar
• Andersen S. (2003). Trajectories of brain development: point of vulnerability or window of opportunity. Neurosci Biobehav Rev 27:3–18.
   PubMed Web of Science ®Google Scholar
• Baykara B, Gencer Ö, İlkin Z, Miral S. (2008). Neurocognitive features of the frontal lobe in parents of autistic children. Turk Psikiyatr Derg 19:225–34.
   PubMed Web of Science ®Google Scholar
• Buffo A, Zagrebelsky M, Huber AB, et al. (2000). Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured purkinje cell axons. J Neurosci 20:2275–86.
   PubMed Web of Science ®Google Scholar
• Cannell JJ. (2010). On theaetiology of autism. Acta Paediatr 99:1128–30.
   PubMed Web of Science ®Google Scholar
• Colantuoni C, Jeon OH, Hyder K, et al. (2001). Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 8:847–65.
   PubMed Web of Science ®Google Scholar
• Comi AM, Zimmerman AW, Frye VH, et al. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388–94.
   PubMed Web of Science ®Google Scholar
• Croen LA, Grether JK, Yoshida CK, et al. (2005). Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a casecontrol study. Arch Pediatr Adolesc Med 159:151–7.
   PubMedGoogle Scholar
• Dahl D, Crosby CJ, Gardner EE, et al. (1982). Purification of the glial fibrillary acidic protein by anion exchange chromatography. Anal Biochem 126:165–9.
   PubMed Web of Science ®Google Scholar
• Delacourte A. (1990). General and dramatic glial reaction in Alzheimer brains. Neurology 40:33–7.
   PubMed Web of Science ®Google Scholar
• Di Pietro V, Amorini AM, Lazzarino G, et al. (2015). S100B and glial fibrillary acidic protein as indexes to monitor damage severity in an in vitro model of traumatic brain injury. Neurochem Res 40:991–9.
   PubMed Web of Science ®Google Scholar
• Eng LF, Ghirnikar RS, Lee YL. (2000). Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439–51.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Laurence JA, Araghi-Niknam M, et al. (2004). Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophr Res 69:317–23.
   PubMed Web of Science ®Google Scholar
• Fontoura P, Steinman L. (2006). Nogo in multiple sclerosis: growing roles of a growth inhibitör. J Neurol Sci 245:201–10.
   PubMed Web of Science ®Google Scholar
• Frick LR, Williams K, Pittenger C. (2013). Micro glial dysregulation in psychiatric disease. Clin Dev Immunol 2013:608–54.
   Google Scholar
• GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. (2000). Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403:439–44.
   PubMed Web of Science ®Google Scholar
• Huber AB, Weinmann O, Brosamle C, et al. (2002). Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22:3553–67.
   PubMed Web of Science ®Google Scholar
• Irwin S, Patel B, Idupulapati M, et al. (2001). Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-x syndrome: a quantitative examination. Am J Med Genet 98:161–7.
   PubMed Web of Science ®Google Scholar
• Kaufmann W, Moser H. (2000). Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 10:981–91.
   PubMed Web of Science ®Google Scholar
• Kempf A, Schwab ME. (2013). Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda) 28:151–63.
   PubMed Web of Science ®Google Scholar
• Keshavan M, Anderson S, Pettergrew J. (1994). Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 28:239–65.
   PubMed Web of Science ®Google Scholar
• Kirkman NJ, Libbey JE, Sweeten TL, et al. (2008). How relevant are GFAP autoantibodies in autism and Tourette Syndrome? J Autism Dev Disord 38:333–41.
   PubMed Web of Science ®Google Scholar
• Laurence JA, Fatemi SH. (2005). Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4:206–10.
   PubMed Web of Science ®Google Scholar
• Mannix R, Eisenberg M, Berry M, et al. (2014). Serum biomarkers predict acute symptom burden in children after concussion: a preliminary study. J Neurotrauma 31:1072–5.
   PubMed Web of Science ®Google Scholar
• Morgan JT, Chana G, Abramson I, et al. (2012). Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456:72–81.
   PubMed Web of Science ®Google Scholar
• Morgan JT, Chana G, Pardo CA, et al. (2010). Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68:368–76.
   PubMed Web of Science ®Google Scholar
• Mychasiuk R, Hehar H, Ma I, et al. (2015). The development of lasting impairments: a mild pediatric brain injury alters gene expression, dendritic morphology, and synaptic connectivity in the prefrontal cortex of rats. Neuroscience 288:145–55.
   PubMed Web of Science ®Google Scholar
• Paolicelli R, Bolasco G, Pagani F, et al. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–8.
   PubMed Web of Science ®Google Scholar
• Papa L, Mittal MK, Ramirez J, et al. (2016). In children and youth with mild and moderate traumatic brain injury GFAP out-performs S100β in detecting traumatic intracranial lesions on CT. J Neurotrauma 33:58–64.
   PubMed Web of Science ®Google Scholar
• Pelinka LE, Kroepfl A, Schmidhammer R, et al. (2004). Glial fibrillary acidic protein in serum after traumatic brain injury brain injury and multiple trauma. J Trauma 57:1006–12.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, et al. (2002). Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57:127–38.
   PubMed Web of Science ®Google Scholar
• Rolando C, Parolisi R, Boda E, et al. (2012). Distinct roles of Nogo-A and Nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration. J Neurosci 32:17788–99.
   PubMed Web of Science ®Google Scholar
• Silva SC, Correia C, Fesel C, et al. (2004). Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunol 152:176–82.
   PubMed Web of Science ®Google Scholar
• Singer HS, Morris CM, Williams PN, et al. (2006). Anti brain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 178:149–55.
   PubMed Web of Science ®Google Scholar
• Singh VK, Warren R, Averett R, Ghaziuddin M. (1997). Circulating auto antibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17:88–90.
   PubMed Web of Science ®Google Scholar
• Sweeten TL, Bowyer SL, Posey DJ, et al. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112:e420.
   PubMed Web of Science ®Google Scholar
• Tetreault NA, Hakeem AY, Jiang S, et al. (2012). Microglia in the cerebral cortex in autism. J Autism Dev Disord 42:2569–84.
   PubMed Web of Science ®Google Scholar
• Toro CT, Hallak JE, Dunham JS, Deakin JF. (2006). Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett 404:276–81.
   PubMed Web of Science ®Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, et al. (2005). Neuro glial activation and neuro inflammation in the brain of patients with autism. Ann Neurol 57:67–81.
   PubMed Web of Science ®Google Scholar
• Webster MJ, Knable MB, Johnston-Wilson N, et al. (2001). Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 15:388–400.
   PubMed Web of Science ®Google Scholar
• Webster MJ, O’Grady J, Kleinman JE, Weickert CS. (2005). Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 133:453–61.
   PubMed Web of Science ®Google Scholar
• Zorner B, Schwab ME. (2010). Anti-Nogo on the go: from animal models to a clinical trial. Ann NY Acad Sci 1198:22–34.
   PubMed Web of Science ®Google Scholar